Ventripoint Enters Collaboration Agreement To Test Echocardiology Technology For Use With Canines

Ventripoint Diagnostics (TSXV: VPT) has entered into a new collaboration agreement as of this morning. The collaboration is with that of the Veterinary Hospital of North Carolina State University, where the company will work to test and evaluation the use of its VMS+ technology in echocardiography of canines.

The unique utilization of the firms echocardiology technology will then look to be expanded for use in all animals. If successful, the collaboration will enable the company to expand and diversify its product portfolio to provide advanced cardiac care for animals.

The technology is believed to enable a better initial assessment in canines than what is currently available for veterinarians on the market. Furthermore, the equipping and training of veterinarians on cardiac assessments using the firms tech would enable earlier detection and treatment of cardiac disease, which is critical to achieving a long-term outcome.

“Companion animals have heart problems, like their owners and so we are delighted to broaden our products to include veterinary services. Initial studies at NCSU have shown the VMS+3.0 can accurately reconstruct and measure the function of canine hearts and this more in-depth evaluation in collaboration with NCSU will verify the results.”

Dr. George Adams, Executive-Chairman of Ventripoint

Ventripoint Diagnostics last traded at $0.08 on the TSX Venture.


FULL DISCLOSURE: Ventripoint Diagnostics is a client of Canacom Group, the parent company of The Deep Dive. The company has been compensated to cover Ventripoint Diagnostics on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

New Found Gold: The Strategic Maritime Resources Purchase

Amex Exploration: Revised Perron PEA Has INSANE Economics

Aris Mining: The Multi Billion Dollar Soto Norte PFS

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

The Future Of 3D Heart Modeling – The Daily Dive feat George Adams

George Adams, CEO of Ventripoint Diagnostics (TSXV: VPT) joins our host Cassandra Leah today to...

Thursday, November 19, 2020, 01:00:00 PM

Ventripoint Diagnostics Removes All Debt From Balance Sheet, Sees Cash Inflows Of $2.1 Million

Ventripoint Diagnostics (TSXV: VPT) is starting today off refreshed, after having cleaned up its a...

Wednesday, February 3, 2021, 08:26:48 AM

Ventripoint Diagnostics Tech To Be Used To Study Atrial Dysfunction In Children

Ventripoint Diagnostics (CSE: VPT) this morning announced the beginning of a new clinical study being...

Tuesday, February 23, 2021, 09:16:45 AM

Providing Echocardiography For Companion Animals – The Daily Dive feat George Adams of Ventripoint

Today on the Daily Dive is that of George Adams, CEO of Ventripoint Diagnostics (TSXV:...

Thursday, January 28, 2021, 01:30:00 PM

George Adams: COVID-19 Damages The Heart – The Daily Dive

Today’s Daily Dive welcomes back Dr. George Adams, Executive Chairman of VentriPoint Diagnostics (TSXV: VPT)....

Friday, September 17, 2021, 01:30:00 PM